ArticleAmerican heart journal plus : cardiology research and practice2025
Evaluation of lipid profile and high sensitive C reactive protein levels among cigarette smokers in East Gojjam, Ethiopia.
Article in American heart journal plus : cardiology research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cigarette smoking is a well-recognized independent risk factor for numerous cardiovascular disorders and contributes to the increasing morbidity and mortality associated with chronic heart diseases (CHD). This study aimed to evaluate how cigarette smoking affects lipid metabolism and inflammatory processes, along with other related mechanisms, in order to better understand the potential cardiovascular risks faced by smokers. Objectives: To evaluate and compare the serum lipid profile and high-sensitivity C-reactive protein levels between cigarette smokers and non-smokers. Methods: A hospital-based comparative cross-sectional study was conducted from December 2023 to May 2024 in East Gojjam, Ethiopia. The study included 150 cigarette smokers and 150 non-smokers. Independent Result: The mean serum levels of total cholesterol, low-density lipoprotein, triglycerides, high-density lipoprotein, and high-sensitivity C-reactive protein in cigarette smokers were 178.46 ± 76.34 mg/dL, 112.36 ± 73.58 mg/dL, 138.80 ± 61.88 mg/dL, 38.33 ± 7.99 mg/dL, and 6.26 ± 5.53 mg/L, respectively. These values were significantly different from those of non-smokers ( Conclusion: Serum mean levels of total cholesterol, low-density lipoprotein, triglycerides, and high-sensitivity C-reactive protein were significantly higher in cigarette smokers compared to non-smokers. In contrast, the mean serum level of high-density lipoprotein was significantly lower in smokers. These changes-elevated TC, LDL-C, TG, and hsCRP, along with decreased HDL-C-may increase the risk of cardiovascular diseases among cigarette smokers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.